Abiomed Announces Preliminary Q3 Results, Slashes View Zacks

ABIOMED, Inc. ABMD recently announced preliminary results for third-quarter fiscal 2020.

Revenues are anticipated at $221.6 million, suggesting a 10% year-over-year rise but below the Zacks Consensus Estimate of $227.1 million.